Aspen Neuroscience

About:

Aspen Neuroscience is a biotechnology company that specializes in personalized cell therapies.

Website: https://www.aspenneuroscience.com

Twitter/X: AspenNeuro

Top Investors: OrbiMed, Alexandria Venture Investments, Gaingels, ARCH Venture Partners, Google Ventures

Description:

Aspen Neuroscience is a development stage and private biotechnology company that uses innovative genomic approaches combined with stem cell biology to deliver patient-specific, restorative cell therapies that modify the course of Parkinson's disease. It is developing induced-pluripotent stem cells (iPSCs) to address diseases with high unmet medical needs, beginning with autologous neuron replacement for both sporadic and genetic forms of Parkinson's disease (PD) and extending across the brain and affected organs.

Total Funding Amount:

$272M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

San Diego, California, United States

Founded Date:

2018-01-01

Contact Email:

info(AT)aspenneuro.com

Founders:

Andres Bratt-Leal, Jeanne Loring

Number of Employees:

51-100

Last Funding Date:

2024-05-15

IPO Status:

Private

Industries:

© 2025 bioDAO.ai